Middle East and Africa Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostics, Minimally Invasive Surgery (MIS), Wound Management, Diabetes Care, Ophthalmic, Dental, Nephrology, General Surgery, and Others), By End User (Hospitals & ASCs, Clinics, and Others), and Regional Forecast, 2025-2032

The Middle East and Africa medical devices market size was valued at USD 23.41 billion in 2024. The market is projected to grow from USD 24.61 billion in 2025 to USD 34.95 billion by 2032, exhibiting a CAGR of 5.1% during the forecast period.

Medical devices consist of a wide range of medical products such as blood pressure monitors, echocardiography devices, surgical stapling devices, and others. The market’s growth is attributed to the growing number of patients visiting hospitals and other healthcare facilities for diagnosis and treatment. Moreover, government support to the market players operating in the region, convergence in medical device regulations, and other factors are also estimated to support the market’s growth in the forecast period.

• For instance, in October 2022, the Ministry of Industry and Advanced Technology (MoIAT) signed several MoUs worth USD 70.8 million with companies to manufacture medical equipment locally. PureHealth, Julphar, and Borouge are among the major companies that are expected to boost exports and increase the UAE's global competitiveness.

Market players such as Nipro Corporation, Shimadzu Corporation, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd have been focusing on new product launches to increase their regional presence.

Market Dynamics

Market Drivers

Hospital Expansions Increase Demand for Medical Supplies In-Turn Accelerating Market Growth

Middle Eastern countries’ healthcare is advancing at a rapid pace with increasing population and patient pool, and demand profile of such diverse populations. The changing profile of healthcare demands expanding healthcare facilities in the region, creating opportunities for key players operating in the market.

• For instance, in April 2022, Gabri Labs announced a strategic partnership with Dubai Science Park to develop a cutting-edge medical device manufacturing facility. This collaboration bolsters Dubai’s position as a premier global hub for healthcare manufacturing and innovation, aligning with the UAE government’s Operation 300bn initiative to accelerate industrial growth and localize production within the healthcare sector.
• Also, according to the 2021 World Index of Healthcare Innovation, the UAE ranked as the 20th best healthcare country in the world.

Such regional growth and expansion are expected to increase the demand for medical supplies and drive market growth.

RESTRAINING FACTORS

Complex Regulatory Environment and Poor Healthcare Infrastructure to Limit Market Growth

The Middle East and Africa medical devices market growth is mainly because of the increased medical care demand among the growing geriatric population and patients suffering from chronic diseases. The increasing demand for effective diagnostics and treatment requires new regional product approvals.

Regulatory authorities such as the South African Health Products Regulatory Authority (SAHPRA) in South Africa and the Ministry of Health and Prevention (MOHAP) in the United Arab Emirates (UAE) are among the regulatory bodies that oversee the registration, classification, and market observation of medical devices to ensure their safety and efficacy in the respective countries of the region.

Despite the structured nature of these regulatory bodies, challenges such as lengthy approval times and complex documentation procedures act as a barrier for the market players in developing and launching products in the country. 

• For instance, regulatory complexity and regular policy updates require market players to adapt and update their clinical study processes continuously, causing product development and launch delays.

Moreover, the poor healthcare infrastructure in the region's developing countries also limits the penetration of technologically advanced products.

Therefore, the complex regulatory scenarios and poor healthcare infrastructures have been restricting the region's market growth. 

Market Opportunities

Increasing Focus of Market Players on Conducting Clinical Studies for Advanced Products Create Expansion Opportunities

Many medical device companies have been focusing on opening new manufacturing capacity in the Middle East and Africa region to expand their product accessibility in the region.

• For instance, AbbVie initiated a clinical trial in June 2024 to study the safety and efficacy of Lutikizumab in prefilled syringes among adult and adolescent subjects with moderate to severe hidradenitis. The expected completion date of the study is in December 2026. The study is being conducted in 242 locations. These locations include the Middle East and Africa regions, such as Saudi Arabia and South Africa.

The increasing focus of the market players in conducting clinical trials for devices in the region has been creating awareness regarding these devices, which anticipated to create demand and growth opportunities in the region.  

Market Challenges

Fragmented Regulatory Scenario Acts as a Challenge for New Product Launches 

Varying approval processes, inconsistent regional requirements, and evolving harmonization efforts create barriers to market entry and delay product launches.

Infrastructure Disparities Act as a Challenge for Market Growth

While GCC countries have advanced systems, many sub-Saharan regions face limited facility coverage, reimbursement constraints, and political instability, hampering adoption.

Middle East and Africa Medical Devices Market Trends

Market Players Emphasize on Partnerships between Associations & Companies to Strengthen Position

Market players such as Medtronic and Olympus Corporation have been focusing on partnerships and collaborations to strengthen their product portfolio in the region.

• For instance, in March 2025, Medtronic announced its partnership with Methinks AI, an AI-driven radiological triage and notification system provider, intending to enhance stroke treatment across Central and Eastern Europe, Africa, Turkey, and the Middle East. This partnership would further strengthen its neurovascular business.

Moreover, the companies have also been focusing on partnerships to expand their offerings in the Middle East and Africa.

• In October 2024, Olympus Corporation partnered with Proximie, a health technology company aiming to provide a health tech platform for digitizing operating rooms. In Europe, the Middle East, and Africa, both companies entered a Reseller Partner Agreement, intending to distribute Olympus Corporation products.

These factors are estimated to expand product offerings in the region and increase the penetration of medical equipment, thereby fueling the Middle East and Africa medical devices market share.

Other Trends

Increasing Improvement in the Healthcare Infrastructure

Saudi Arabia, UAE, Qatar, and Egypt are actively upgrading hospitals and diagnostic centers and partnering with market players with an aim to drive the adoption of sophisticated medical devices.

Increasing Demand for Monitoring Devices

Demand for monitoring devices (including wearable and portable tools) and diagnostic imaging systems is increasing in the region owing to increasing prevalence of cardiac disorders.

Increasing Demand for Wearable and Homecare Devices

Use of remote patient monitoring and wearable devices increased post-pandemic. The growing demand for chronic disease management and telehealth integration further supports its demand.

Growing Expansion of Contract Manufacturing

As device demand increases, outsourcing to regional hubs such as the UAE, Saudi Arabia, and Turkey is growing. Automation, AI, IoT, and smart manufacturing practices support scalability and quality compliance.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Type

Focus of Market Players on Improving Production Capabilities Aids In-vitro Diagnostics Growth

On the basis of type, the market is classified into orthopedic devices, cardiovascular devices, diagnostic imaging, in-vitro diagnostics, minimally invasive surgery (MIS), wound management, diabetes care, ophthalmic, dental, nephrology, general surgery, and others.

The in-vitro diagnostics segment dominated the market by accounting for a major portion share in 2024. The segment’s growth is attributed to the increasing emphasis of the market players on the expansion of their production capabilities in the region.

• For instance, in January 2024, Codix Pharma Limited, through its subsidiary Colexa Biosensor Limited, inaugurated its first IVD manufacturing capacity in Lagos, Nigeria. With this development, the company aimed at addressing diabetes prevalence in Africa by manufacturing blood glucose meters and strips.

The dental segment is expected to grow at the fastest CAGR throughout the study period driven by the growing burden of dental disorders and rising awareness regarding dental treatment products such as aligners in the region.

To know how our report can help streamline your business, Speak to Analyst

By End User

Hospitals & ASCs lead as Private and Government Organizations Partner with Hospitals to Enhance Treatment

By end user, the market is segmented into hospitals & ASCs, clinics, and others. The hospitals & ASCs segment dominated the market in 2024 and is expected to grow at the fastest CAGR. The growing burden of chronic disorders, along with the increasing focus of the government and private organizations on partnerships with hospitals to enhance their medical care facilities, is responsible for the segment’s dominance.

• For instance, in July 2025, the PureHealth Group partnered with Cincinnati Children’s Hospital in the U.S., intending to deliver advanced and top-global paediatric healthcare expertise in Abu Dhabi and the UAE.

The clinics segment is expected to grow significantly during the forecast period with an increasing number of privately held clinics and a surge in the regional economy. The availability of skilled surgeons and advanced instruments is an important factor contributing to the segment's growth.

Middle East and Africa Medical Devices Market Regional Outlook

Based on geography, the market is studied across the GCC, South Africa, and rest of the Middle East and Africa.

The market in GCC accounted for the maximum portion of the total Middle East & Africa market by generating a market value of USD 10.71 billion in 2024. Rising healthcare expenditures, high disposable incomes, and the growing prevalence of chronic diseases in the region are significant factors propelling the market's growth. Also, the rise in the number of medical conferences in the GCC countries that involve gathering healthcare professionals and allowing key players to showcase their medical products is another factor enhancing market growth across the GCC countries.

• For example, in April 2025, the first Gulf General Surgery Societies Conference was held in Riyadh, Saudi Arabia, from 25th to 27th April 2025. Several market players were present during the event to showcase their surgical products and create brand awareness among the consumers.

Moreover, the market in South Africa is expected to grow significantly during the forecast period. The increasing prevalence of infectious diseases in the country has been fueling the demand for effective diagnostics and treatment options.

Moreover, the market in the rest of the Middle East and Africa is expected to grow substantially during the forecast period. The growing awareness regarding effective diagnosis and treatment options is expected to fuel the market growth in the forecast period.

KEY INDUSTRY PLAYERS

Focus of Market Players on Showcasing their Products to Strengthen their Brand Presence in the Region

Players such as Koninklijke Philips N.V., GE HealthCare, and Medtronic are significant players in the Middle East and Africa medical devices market. Their increasing focus on showcasing products in the regional market is responsible for their revenue growth.

• For instance, in January 2025, Koninklijke Philips N.V. showcased its latest innovations, which included a next-generation BlueSeal helium-free MRI system, integrated with AI-enabled smart reading, AI-enabled CT 5300, EPIQ Elite Elevate, and Affiniti ultrasound systems at the Arab Health 2025, which occurred in Dubai, UAE.

Other prominent players, such as Siemens Healthcare Private Limited, F. Hoffmann-La Roche Ltd, and Stryker, are also leading the market growth due to their strong distribution network and diverse product portfolio indications. These companies are focused on strengthening their product portfolio and distribution network through strategic collaboration and partnerships.

LIST OF KEY MEDICAL DEVICES PLAYERS IN THE MIDDLE EAST & AFRICA:

• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthcare Private Limited (Germany)
• B. Braun SE (Germany)
• Getinge AB (Sweden)
• Drägerwerk AG & Co. KgaA (Germany)
• Medtronic (Ireland)
• GE Healthcare (U.S.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Stryker (U.S.)
• Johnson & Johnson (U.S.)

KEY INDUSTRY DEVELOPMENTS

• July 2025: Medtronic announced a strategic partnership with Koninklijke Philips N.V. with an aim to improve and expand patient care technology.
• June 2025: Stryker announced the Food and Drug Administration (FDA) approval of the total ankle system, indicated for patients with ankle joints damaged by post-traumatic, severe rheumatoid, or degenerative arthritis.
• February 2024: Siemens Healthcare Private Limited announced the expansion of its strategic partnership with Dallah Health, a premier healthcare provider in Saudi Arabia, with an aim to enhance healthcare delivery in the country.
• January 2024: Koninklijke Philips N.V. showcased its advanced technological advancements at the Arab Health 2024 to help hospitals and other healthcare systems deliver high-quality services to their patients.
• October 2021: F. Hoffmann-La Roche Ltd, in partnership with Retina Pharmaceuticals, inaugurated cobas 6800 and 8800 systems with an aim to expand molecular diagnostics in Addis Ababa, Ethiopia.

REPORT COVERAGE

The report provides qualitative and quantitative insights and a detailed information on the Middle East and Africa market analysis, size, and growth rate for all possible segments. The research report elaborates on market dynamics and competitive landscape along with the market forecast. Various key insights presented in the report are an overview of the number of procedures, an overview of price analysis of types of products, an overview of the regulatory scenario by key countries, pipeline analysis, new product launches, key industry developments – mergers, acquisitions & partnerships on the market.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation